Adapting a memory test for Reunion islanders
Part of Mental health clinical trials.
This study adapts the Mini-Mental State Exam (MMSE), a short test of memory and thinking, to be more accurate for people living in Reunion Island. If you are 60–89 and either have a cognitive disorder or are a healthy volunteer, you may help improve dementia screening.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 60 and 89 years old.
- You have lived in Reunion Island for more than 5 years.
- You either have a diagnosis of Alzheimer's or vascular cognitive disorder, or you are a healthy volunteer without any cognitive issues.
- You can understand the test instructions and are available for one hour.
- You are covered by French social security and can give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new tool called the Monument Test, which checks how well people can name and recognize famous landmarks or unique items. It may help assess memory and thinking skills in adults with or without Alzheimer's disease.
This study creates a practical tool to measure “episodic memory,” which is your ability to recall events from daily life. It includes adults age 70+ with different memory levels, to see how well the tool works for people with dementia and for those without.
This study tests quick new methods to measure “slowed actions” in people with stroke or memory-related brain conditions. The goal is to see whether these quick tests can help predict future outcomes and guide care.
This study looks at past memory test scores to see if they can predict how quickly memory declines in people with Alzheimer's disease. It aims to help doctors plan better care.
This study looks at how common mild cognitive impairment and dementia are in people staying in rehabilitation units for heart, lung, or orthopedic problems. It aims to understand memory and thinking issues that may be overlooked in these settings.
This study is testing a new way to measure memory and thinking in people with Alzheimer's disease. Taking part could help researchers find better tools to track the disease and might help you understand your own condition better.
Hear when a new Alzheimer s Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.